Noninfringement Defense Based on Prior Commercial Use Under 35 U.S.C. § 273 Must Be Timely and Expressly Pleaded

May 9, 2024

Reading Time : 2 min

The district court in a patent infringement case granted plaintiff’s ex parte request to strike defendant’s prior use defense under 35 U.S.C. § 273. Because defendant failed to plead the defense and did not raise it until just prior to the final pretrial conference, the court struck the defense as untimely.

Amended by the America Invents Act in 2011, Section 273 provides a noninfringement defense to a claim for patent infringement based on the defendant’s prior commercial use of the claimed product. This defense is separate and distinct from an invalidity defense based on prior public use under Section 102(a). And to rely on it, the defendant must introduce clear and convincing evidence that the defendant commercially used a product that meets the claim limitations prior to the effective filing date of the claims.

Here, after the court granted plaintiff’s motion for summary judgment of no invalidity, defendant sought to raise a defense under Section 273. In response, plaintiff filed an ex parte request to strike the defense as untimely. According to plaintiff, the first-time defendant had raised the defense was in its pretrial Memorandum of Contentions of Fact and Law. Defendant argued that it had pleaded facts consistent with a prior use defense. But the court struck the defense, holding that defendant had to actually plead a prior commercial use defense to infringement and could not merely rely on background facts consistent with the defense to establish that the defense had been timely raised. The court noted that the statutory language of Section 273(f), which requires a reasonable basis for asserting the defense, also suggests that the defense must be actually pleaded. 

Relatedly, the court granted-in-part plaintiff’s motion in limine seeking to exclude defendant’s arguments and evidence comparing its own products to prior art devices. Defendant argued that these comparisons were relevant to plaintiff’s infringement claims, defendant’s prior use defense to infringement and damages. Because the court struck defendant’s purported prior commercial use defense as untimely and concluded that the evidence was irrelevant to infringement, the court excluded defendant’s evidence and arguments suggesting that its own products practice the prior art. The court did, however, refrain from excluding defendant’s arguments and evidence for the narrow purpose of potentially rebutting plaintiff’s willful infringement arguments by showing that defendant had a good faith belief that the asserted patents were invalid. 

Practice Tip: Although some defendants may be hesitant to rely on Section 273, which requires clear and convincing evidence that the accused product meets the claim limitations, the defense may still be useful where, for example, infringement is not contested. But if a defendant wants to assert the prior commercial use defense, the defense should be raised expressly in the pleadings to avoid waiver. Alleging facts that are merely consistent with the defense will not be sufficient. 

Delta T LLC v. MacroAir Technologies, Inc., Case Nos. 5:20-cv-00728-GW-GJS, D.I. 399 (C.D. Cal. Apr. 19, 2024).

Share This Insight

Previous Entries

IP Newsflash

August 11, 2025

In considering a motion to dismiss infringement claims for two related patents, the District of Massachusetts recently held that pre-suit knowledge of a “parent” patent, without more, is insufficient to establish pre-suit knowledge of the “child” patent for purposes of indirect and willful infringement.

...

Read More

IP Newsflash

August 8, 2025

Following a jury verdict finding trade secret misappropriation, the District Court for the District of Massachusetts granted-in-part a plaintiff’s motion for a permanent injunction to prohibit defendants from using plaintiff’s trade secrets. The district court further required defendants to reassign to plaintiff patents and patent applications that disclosed or were derived from plaintiff’s trade secrets as part of its equitable relief.

...

Read More

IP Newsflash

August 6, 2025

In ruling on a recent motion to strike, a judge in the Eastern District of Texas permitted a damages expert to rely on a damages theory based on defendant’s “avoided costs,” holding that this theory did not run afoul of the “entire market value rule.”

...

Read More

IP Newsflash

August 5, 2025

The Federal Circuit recently vacated a decision by the Patent Trial and Appeal Board after concluding that the board’s analysis of licensing evidence offered as a secondary consideration of nonobviousness constituted legal error and was not supported by substantial evidence. According to the court, the board applied a more exacting and improperly heightened nexus standard than is required by law for license evidence.

...

Read More

IP Newsflash

August 5, 2025

A Northern District of California judge recently granted a motion to reconsider his summary judgment ruling that defendant was barred from raising certain “device art” due to IPR estoppel under 35 U.S.C. § 315(e)(2). In the original ruling, the judge adopted the broader rule that IPR estoppel applies to device art that is “materially identical” to patents or printed publications that petitioners raised, or could have raised, in an IPR. Following that ruling, however, the Federal Circuit issued its Ingenico decision adopting the narrower view that IPR estoppel applies only to “grounds” based on patents and printed publications and not to device-based grounds. Citing Ingenico as a “change of law,” defendant moved for reconsideration of the court’s ruling, and the court granted the motion.

...

Read More

IP Newsflash

August 5, 2025

In a recent decision designated as Informative, the USPTO Director determined that the Patent Trial and Appeal Board abused its discretion by instituting two inter partes review proceedings challenging the same patent, based on petitions advancing different constructions of the same claim term. The Director expressed concerns that permitting multiple petitions based on alternative claim constructions effectively circumvents word count limitations, strains board resources, and undermines procedural efficiency.

...

Read More

IP Newsflash

July 25, 2025

Earlier this year, the Federal Circuit’s decision in Qualcomm Inc. v. Apple Inc. (Qualcomm II) raised questions about the extent to which petitioners can rely on applicant admitted prior art (“AAPA”) in inter partes review proceedings.  The Federal Circuit’s recent decision in Shockwave Medical, Inc. v. Cardiovascular Sys., Inc. largely cabins the Qualcomm II decision to its particular facts and makes clear that AAPA can be used as evidence of background knowledge as part of an obviousness argument.

...

Read More

IP Newsflash

July 11, 2025

The Federal Circuit recently reversed a PTAB determination on remand that a patent was obvious over applicant admitted prior art (“AAPA”) in combination with prior art patents, holding that expressly designating AAPA as a “basis” for a ground is improper under 35 U.S.C. § 311(b). In doing so, the Court rejected the PTAB’s “blanket rule” that “AAPA used in combination with prior art patents or printed publications under § 311(b) is ipso facto not the basis or part of the basis of a ground.” Ultimately, while the case clarifies that expressly listing AAPA in an IPR ground is improper, the precise line between proper and improper uses of AAPA in other instances remains unclear.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.